CMV infections after hematopoietic stem cell transplantation

Bone Marrow Transplantation
P Ljungman

Abstract

CMV can cause disease in several different organs after SCT. Seropositivity remains a major risk factor for TRM in unrelated SCT patients. In a study using the EBMT registry, CMV-seropositive patients receiving seropositive unrelated donor grafts had improved survival and reduced TRM compared with those receiving seronegative grafts, and a similar result was found in a single center study. Preventive measures can be divided into prevention of a primary infection or recurrence of CMV (prophylaxis) or prevention of development of disease when a reactivation has occurred (preemptive therapy). The standard therapy for CMV pneumonia has been i.v. ganciclovir combined with high-dose Ig, but this standard has never been evaluated in a controlled study and more recent studies have questioned whether the addition of Ig improves outcome.

References

Feb 7, 2002·Blood·Pierre ReusserUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Jan 30, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Olle RingdénMats Remberger
Sep 15, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·S CesaroC Messina
Dec 6, 2005·Antiviral Research·Suzanne J F KapteinManfred Marschall
Jan 18, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Per Ljungman
Apr 21, 2006·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M E LeviJ L Olson
Aug 8, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·G GernaT Rampino

❮ Previous
Next ❯

Citations

Dec 18, 2013·Medical Microbiology and Immunology·K FrenzelJ Hofmann
Oct 22, 2010·The Journal of Antimicrobial Chemotherapy·Sébastien HantzUNKNOWN French CMV Resistance Survey Study Group
Feb 20, 2010·Nature Reviews. Cancer·Robert R Jenq, Marcel R M van den Brink
Mar 20, 2013·Current Opinion in Pulmonary Medicine·Gauri Godbole, Vanya Gant
Dec 22, 2010·Expert Review of Molecular Diagnostics·Stefano Giulieri, Oriol Manuel
Jul 25, 2009·Expert Review of Vaccines·Wolfgang Herr, Bodo Plachter
Oct 15, 2011·Pathologie-biologie·L MhiriUNKNOWN Groupe Contrôle de qualité national cytomégalovirus (CQNCMV)
Jan 18, 2011·Hematology/oncology Clinics of North America·Per LjungmanMichael Boeckh
May 15, 2010·Infectious Disease Clinics of North America·Per LjungmanMichael Boeckh
Dec 3, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Sophie ServaisMarie-Christine Mazeron
Jul 31, 2009·Cancer·Alois GratwohlUNKNOWN European Group for Blood and Marrow Transplantation and the European Leukemia Net
Mar 22, 2012·Pediatric Blood & Cancer·José Eugenio Vázquez-MerazJuan Manuel Mejía Arangure
Jan 4, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C da Cunha-BangJ D Lundgren
Nov 29, 2014·Transplant Infectious Disease : an Official Journal of the Transplantation Society·K Terasako-SaitoY Kanda
Aug 30, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Beatriz Muñoz-CoboDavid Navarro
Apr 24, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G VentonJ El-Cheikh
Nov 30, 2004·The Lancet Infectious Diseases·Maher K Gandhi, Rajiv Khanna
Sep 11, 2016·Virulence·Agnieszka Wójtowicz, Pierre-Yves Bochud
Sep 30, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Jim H NomuraFiroozeh Sahebi
Jun 12, 2013·Journal of Intensive Care Medicine·Giovanna Travi, Steven A Pergam
May 18, 2017·Transplant International : Official Journal of the European Society for Organ Transplantation·Amr BadawyShinji Uemoto
Sep 19, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Miriam CiáurrizEduardo Olavarría
Apr 12, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Stefan K ZöllnerAndreas H Groll
May 13, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·María Suárez-LledóMontserrat Rovira
Jul 22, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Chien-Ting LinHwei-Fang Tien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.